Pharma stocks crashed after Trump announced a phased tariff plan on generic drug imports. Tariffs will remain zero until August 2028, rise to 100%, then double to 200% by 2029. Indian firms like Sun Pharma, Lupin, and Aurobindo saw sharp declines as investors feared long-term earnings impact and manufacturing shifts.
Business
Pharma Stocks Crash As Trump Unveils Tariff Plan On Drug Imports
